Livzon Pharmaceutical Group Inc. (SHE:000513)
26.23
-0.01 (-0.04%)
Sep 18, 2026, 3:04 PM CST
SHE:000513 Market Cap
SHE:000513 has a market cap or net worth of 20.65 billion as of September 18, 2026. Its market cap has decreased by -38.15% in one year.
Market Cap
20.65B
Enterprise Value
17.03B
Revenue
10.75B
Ranking
n/a
PE Ratio
13.93
Stock Price
26.23
ChartMarket Cap Chart
Since July 14, 1997, SHE:000513's market cap has increased from 392.67M to 20.65B, an increase of 5,158.88%. That is a compound annual growth rate of 14.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 20.65B | -26.12% |
| Dec 31, 2025 | 27.95B | -8.97% |
| Dec 31, 2024 | 30.70B | 8.53% |
| Dec 29, 2023 | 28.29B | 3.04% |
| Dec 30, 2022 | 27.46B | -15.01% |
| Dec 31, 2021 | 32.31B | -2.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 23.02B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 21.83B |
| Walvax Biotechnology | 21.29B |
| Shanghai Haoyuan Chemexpress | 21.07B |
| Hybio Pharmaceutical | 20.76B |
| Tasly Pharmaceutical Group | 20.71B |
| Jilin Aodong Pharmaceutical Group | 20.59B |
| Guangdong Zhongsheng Pharmaceutical | 20.59B |